How bad is Wegovy for you, honestly?

Gastrointestinal side effects are the most common — nausea, vomiting and diarrhoea affect many people, especially in the early weeks of treatment.
Serious but uncommon risks include acute pancreatitis; the MHRA issued a formal Drug Safety Update on GLP-1 medicines highlighting this in January 2026.
Wegovy is not recommended during pregnancy, breastfeeding or when trying to conceive, and it is not licensed for anyone under 18.
A GPhC-registered Independent Prescriber reviews every application individually — your medical history, not a checklist, determines suitability.

Wegovy is a prescription-only medicine, and like every medicine it carries real risks alongside real benefits. Most people tolerate it reasonably well, but side effects are common, and a small number experience something serious enough to stop treatment. Whether Wegovy is bad for you specifically depends on your health history, which is exactly why a prescriber has to assess you before it can be dispensed. This page sets out what the evidence actually shows, so you can have an informed conversation rather than going in blind.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The real risks of Wegovy: what's mild, what's manageable, and what needs urgent attention

The decision you're actually making

When people ask whether Wegovy is bad for you, they're usually weighing one of two things: the discomfort of side effects against the potential benefits, or the safety of a medicine dispensed online against their instinct to be cautious. Both are reasonable. Wegovy contains semaglutide, a GLP-1 receptor agonist that slows gastric emptying and reduces appetite, and that mechanism is precisely why it causes gastrointestinal symptoms in so many users. If you want to understand whether semaglutide is bad for you in a broader sense, it helps to look at both the mechanism and the individual risk factors that prescribers weigh up. The medicine doing its job and the medicine causing nausea are, frustratingly, linked.

The NHS medicines page for semaglutide lists the common side effects clearly: nausea, vomiting, diarrhoea, constipation, indigestion, reflux, burping, fatigue, headache, dizziness and injection-site reactions. These tend to be worst in the first few weeks or after a dose increase, and for many people they settle. That said, around one in ten users in clinical trials found them severe enough to stop treatment. Knowing that upfront helps you plan.

There are also factors that make Wegovy genuinely unsuitable rather than just uncomfortable. A history of pancreatitis, certain thyroid conditions such as medullary thyroid carcinoma or MEN2 syndrome, or active gallbladder disease are the kinds of contraindications your prescriber will specifically check. Wegovy is not bad for you in an across-the-board sense, but it can be bad for specific people, and the clinical assessment exists precisely to sort that out. If you want to understand the broader picture on semaglutide's profile, our semaglutide overview covers the mechanism and evidence in more depth.

The serious risks: rare but worth knowing

Serious adverse events on Wegovy are uncommon, but they are real. The one that receives the most regulatory attention is acute pancreatitis. In January 2026 the MHRA issued a Drug Safety Update on GLP-1 medicines specifically flagging pancreatitis as a known infrequent risk that can be severe. The symptom to act on is persistent, severe stomach pain that spreads to the back, with or without vomiting. If that happens, stop the injection and seek urgent medical attention. Don't wait to see if it settles.

Gallbladder problems, including gallstones, are also noted in the prescribing information, particularly with rapid weight loss. Dehydration from prolonged vomiting or diarrhoea can put the kidneys under strain. A small number of users experience mood changes or, in rare cases, thoughts of self-harm, the prescribing guidance recommends monitoring for this, and it's worth being honest with your prescriber if your mood shifts noticeably during treatment.

One practical habit worth building: at the start of each new pen, take thirty seconds to check the liquid looks clear and colourless through the window. Cloudy, discoloured or particulate liquid shouldn't be injected, that's your immediate visual check. Anything that looks wrong should be reported to your pharmacy and, if you suspect a counterfeit, to the MHRA's Yellow Card scheme.

For a full rundown of what's known about gastrointestinal symptoms specifically, our page on wind and bloating on Wegovy goes into practical detail on what to expect and how to manage it.

Who it isn't suitable for, and what the evidence says about everyone else

Wegovy is licensed in the UK for adults with a BMI of 30 or above, or 27 and above if they have at least one weight-related condition such as high blood pressure, high cholesterol or type 2 diabetes. Lower thresholds apply for some ethnic backgrounds under UK guidance. Being within those numbers doesn't automatically make it appropriate, the prescriber assesses the complete picture, including other medicines you take and conditions you have.

Pregnancy is a firm contraindication. Wegovy is not recommended while pregnant, while breastfeeding, or in the months before trying to conceive. Women using oral contraceptives should discuss timing with their prescriber; for tirzepatide specifically there is guidance on adding a barrier method in the early weeks of treatment, though the contraception picture differs between medicines. Anyone who is under 18 falls outside the licensed age range. These are not edge cases, they come up frequently, and a conscientious prescriber will ask about all of them.

For the majority of adults who do meet the criteria, the STEP 1 trial (68 weeks, published in the New England Journal of Medicine) showed an average weight loss of around 15% at the 2.4 mg maintenance dose, meaningful reductions that carry their own cardiovascular and metabolic benefits. The question isn't whether Wegovy is universally bad or universally fine; it's whether the risk-benefit balance makes sense for you as an individual. That calculation belongs in a clinical conversation, not a search bar. You can explore who Wegovy suits for more on that balance, or read about how people weigh up Wegovy's pros and cons in practice.

Getting Wegovy safely if you decide to go ahead

If a prescriber concludes that the benefits outweigh the risks for you, the next question is where to get it legitimately. Wegovy is a prescription-only medicine; it cannot legally be sold without one. The risk of buying from unverified online sellers isn't hypothetical, the MHRA has flagged fake pens containing harmful substances, and large-scale counterfeit operations have been prosecuted. Any seller advertising Wegovy without requiring a clinical assessment first is a red flag worth taking seriously.

At nume, every application is read personally by a GPhC-registered Independent Prescriber (a real clinician, not an automated system) on the same day it arrives. Identity is verified, weight is confirmed on a live video call, and GP notification is sent in line with GPhC guidance. You can verify our pharmacy on the GPhC register directly. If approved, treatment is dispatched the same day for free next-working-day delivery. There's no subscription and no auto-renewal; every repeat order goes through the same clinical check.

For context on what a private prescription typically costs and what a legitimate price should include, our guide to buying Wegovy in the UK covers what to look for and what to avoid. And if after reading all of this you want a prescriber to review your individual situation, you can speak to our prescribers through a free consultation.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions